Related Experiment Video
Updated: Mar 26, 2026
04:49
Automated Counterflow Centrifugal System for Small-Scale Cell Processing
Published on: December 12, 2019
9.9K
Technological developments for small-scale downstream processing of cell therapies.
R Lee Buckler1, Eric J Kunkel2, Maria L Thompson2
1RepliCel, Life Sciences, Inc., Vancouver, British Columbia, Canada.
Cytotherapy
|February 10, 2016
Summary
Cell-based therapies are advancing despite challenges. Novel downstream processing technologies are crucial for efficient and reliable distribution from manufacturing to patients, making these therapies a reality.
Area of Science:
- Biotechnology
- Regenerative Medicine
- Cell Therapy Manufacturing
Background:
- Cell-based therapies are increasingly prevalent, facing regulatory and clinical challenges.
- Advancements in manufacturing and processing are essential for commercializing these therapies.
- Efficient distribution is key to realizing the potential of cell therapies.
Purpose of the Study:
- To highlight the importance of downstream processing in cell therapy development.
- To discuss how modern technologies address distribution challenges.
- To emphasize the role of small-scale solutions in advancing cell therapy accessibility.
Main Methods:
- Review of current downstream processing technologies for cell therapies.
- Analysis of innovations in manufacturing and distribution logistics.
- Focus on small-scale solutions for enhanced efficiency and reliability.
Main Results:
- Downstream processing technologies are critical for the successful scale-up and distribution of cell therapies.
- Modern solutions improve the efficiency and reliability of delivering therapies to patients.
- Small-scale downstream processing innovations are pivotal in bridging the gap between development and clinical application.
Conclusions:
- Continued innovation in downstream processing is vital for the widespread adoption of cell-based therapies.
- Technological advancements in manufacturing and distribution are overcoming key hurdles.
- Small-scale solutions represent a significant step towards making cell therapies a clinical reality.
Related Concept Videos
01:27Upstream Processing
36
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
36
01:20Overview Of Cell Separation And Isolation
8.2K
Cell separation was first achieved in 1964 by S. H. Seal, who separated large tumor cells from the smaller blood cells using filtration. Two years later, Pohl and Hawk performed experiments on how cells respond differently to a nonuniform electric field based on the cell type. Such observations were the inception of cell separation methods, which allow isolating a single cell type from a heterogeneous sample.
8.2K
01:14Scale-Up Processes
33
The scale-up of microbial fermentation processes is essential in industrial biotechnology, allowing the transition from laboratory-scale experiments to commercial-scale production while aiming to maintain product yield and quality. This process requires meticulous adjustment of equipment design, process parameters, and contamination control strategies to accommodate increasing culture volumes.At the laboratory scale, cultures are typically maintained in 1 to 10-liter glass or autoclavable...
33